<DOC>
	<DOCNO>NCT00264901</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . This trial aim comparison safety efficacy subject type 2 diabetes use either self titration physician guide titration accord local standard care .</brief_summary>
	<brief_title>Comparison Self Adjustment Versus Standard Care Treatment Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Diagnosis type 2 diabetes HbA1C &lt; = 12.0 % within past 12 month ; BMI &lt; = 45.0 kg/m2 Initiation , addition , change , continuation basal insulin therapy insulin detemir deem necessary Investigator Anticipated change concomitant medication know interfere glucose metabolism systemic steroid , nonselective betablockers mono amine oxidase ( MAO ) inhibitor . Proliferative retinopathy maculopathy require acute treatment within last 6 month . Any glucose lowering medication indicate combination insulin , GLP1 Analogues Known hypoglycemia unawareness recurrent major hypoglycemia , judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>